• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 11500A
Device Problems Fluid/Blood Leak (1250); Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problems Stroke/CVA (1770); Endocarditis (1834); Insufficient Information (4580)
Event Type  Injury  
Manufacturer Narrative
The device was explanted > 0 days for unknown reasons.Although there are multiple root causes, valves are typically explanted because they are not functioning optimally.In this case, intervention has been performed.Additional information and product return for evaluation have been requested.However, there has been no response at this time.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
Edwards lifesciences maintains an implant patient registry (ipr).This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional "customer complaint".The information reported may or may not be related to the edwards device.It was reported via the implant patient registry that this inspiris resilia valve model 11500a25 was explanted from the aortic position after an implant duration of six (6) months for unknown reason.A valve model 11500a23 was implanted in replacement.This case involved a patient who was 56 years old at the time of the reported event and who was noted as to be in recovery after the procedure.
 
Manufacturer Narrative
H10: additional narrative: based on the additional information obtained, this event is no longer considered reportable and this correction is being submitted.
 
Event Description
Edwards lifesciences maintains an implant patient registry (ipr).This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional "customer complaint".The information reported may or may not be related to the edwards device.It was reported via the implant patient registry that this inspiris resilia valve model 11500a25 was explanted from the aortic position after an implant duration of four (4) months due to endocarditis leading to regurgitation.The prosthetic valve was found to have multiple small vegetations.Two months after implant, patient was feeling unwell with fevers and night sweats and was found to have positive blood culture.The infecting organism of endocarditis was enterococcus faecalis after an urinary tract infection (uti).Patient was admitted to hospital and also found to have occipital stroke with his enterococcus faecalis bacteremia.Patient finished six weeks of antibiotics and was readmitted two months later with positive cultures.A valve model 11500a23 was implanted in replacement with no complications.The patient was noted as to be in recovery and feeling well after the procedure and was discharged on pod #30.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INSPIRIS RESILIA AORTIC VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
irvine CA 92614
Manufacturer Contact
reginald santos
one edwards way
ant 6.1
irvine, CA 92614
9492502731
MDR Report Key15103568
MDR Text Key296584069
Report Number2015691-2022-07011
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number11500A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/27/2022
Initial Date FDA Received07/26/2022
Supplement Dates Manufacturer Received07/26/2022
Supplement Dates FDA Received08/19/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention; Hospitalization;
Patient Age56 YR
Patient SexMale
-
-